BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 31416432)

  • 1. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Jan; 19(1):115. PubMed ID: 30691416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study.
    Hibstie YT; Kibret GD; Talie A; Temesgen B; Melkamu MW; Alebel A
    PLoS One; 2020; 15(9):e0239013. PubMed ID: 32931502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.
    Ardura-Garcia C; Feldacker C; Tweya H; Chaweza T; Kalulu M; Phiri S; Wang D; Weigel R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):e160-7. PubMed ID: 26218409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART.
    Nuwagaba-Biribonwoha H; Kiragga AN; Yiannoutsos CT; Musick BS; Wools-Kaloustian KK; Ayaya S; Wolf H; Lugina E; Ssali J; Abrams EJ; Elul B;
    J Int AIDS Soc; 2018 Sep; 21(9):e25178. PubMed ID: 30225908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.
    Schöni-Affolter F; Keiser O; Mwango A; Stringer J; Ledergerber B; Mulenga L; Bucher HC; Westfall AO; Calmy A; Boulle A; Chintu N; Egger M; Chi BH; ;
    PLoS One; 2011; 6(12):e27919. PubMed ID: 22205933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
    Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
    BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa.
    Chandiwana N; Sawry S; Chersich M; Kachingwe E; Makhathini B; Fairlie L
    Medicine (Baltimore); 2018 Jul; 97(29):e10901. PubMed ID: 30024494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
    Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
    BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India.
    Nimkar S; Valvi C; Kadam D; Rewari BB; Kinikar A; Gupte N; Suryavanshi N; Deluca A; Shankar A; Golub J; Bollinger R; Gupta A; Marbaniang I; Mave V
    HIV Med; 2018 Jul; 19(6):395-402. PubMed ID: 29573312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
    Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
    BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
    Baldé A; Lièvre L; Maiga AI; Diallo F; Maiga IA; Costagliola D; Abgrall S
    PLoS One; 2020; 15(9):e0238687. PubMed ID: 32911516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program.
    Kawilapat S; Salvadori N; Ngo-Giang-Huong N; Decker L; Kanjanavanit S; Puangsombat A; Preedisripipat K; Lertpienthum N; Akarathum N; Mekmullica J; Srirompotong U; Lallemant M; Le Coeur S; Traisathit P; Leroi C; Jourdain G
    PLoS One; 2019; 14(9):e0222082. PubMed ID: 31527875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decentralizing Access to Antiretroviral Therapy for Children Living with HIV in Swaziland.
    Auld AF; Nuwagaba-Biribonwoha H; Azih C; Kamiru H; Baughman AL; Agolory S; Abrams E; Ellerbrock TV; Okello V; Bicego G; Ehrenkranz P
    Pediatr Infect Dis J; 2016 Aug; 35(8):886-93. PubMed ID: 26849157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
    Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
    Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.